Vitamin D 1,25-Dihydroxy
Vitamin D is a fat-soluble steroid hormone that occurs in two forms: Vitamin D3 (cholecalciferol) and Vitamin D2 (ergocalciferol). Vitamin D3 is obtained from foods of animal origin and ultraviolet light-stimulated conversion of 7-dehydrocholesterol in the skin. Small amounts of D2 are obtained from foods of plant origin. Both forms are metabolized to their respective 25(OH)D forms. Both D2 and D3 are of equivalent biologic activity in vivo.
Vitamin D is stored in adipose (fatty) tissue and enters the circulation bound to vitamin D binding protein (VDBP) and albumin. In the liver, vitamin D is hydroxylated (an OH or hydroxyl group is added to the molecule) to produce 25(OH)D. 25(OH)D is further hydroxylated in the kidney by 1-α-hydroxylase to produce 1,25(OH)2D. This occurs under direct regulation by parathyroid hormone (PTH) and ionized calcium levels. This forms the biologically-active calcitropic hormone 1,25-dihydroxy vitamin D. In patients without kidneys, 1,25(OH)2D is not detectable. 1,25(OH)2D (both D2 and D3), also known as calcitriol is the most potent form of vitamin D and is the hormonally active form of Vitamin D. It plays an integral role in calcium regulation and in the maintenance of healthy bone. In addition, it stimulates the absorption of calcium by the intestine and may also serve to increase calcium and phosphate reabsorption in the kidney. Primary hyperparathyroidism is usually associated with increased plasma 1,25(OH)2D.
A deficiency of Vitamin D results in malformation of bone due to mineralization defects, producing rickets in children, and osteomalacia in adults. It is often useful to measure both PTH and 1,25(OH)2D. Measurement of plasma 1,25(OH)2D is not the best measure of overall Vitamin D status, whereas serum 25(OH)D measurement more accuratly reflects Vitamin D status.
- Diagnosis of vitamin D deficiencies or intoxication
- Rule out vitamin D deficiency as cause of bone disease
- Differential diagnosis of hypercalcemia, hypocalcemia, and hypercalciuria
- Differential diagnosis of 1-alpha-hydroxylase deficiency from 1,25(OH)2D-resistant rickets
- Monitoring vitamin D status of patients with chronic renal failure
- Differentiating primary hyperparathyroidism from hypercalcemia of cancer
- Differentiating between Vitamin-D-resistant from Vitamin-D-responsive rickets
- As an aid in diagnosis and management of sarcoidosis
Increased in:
- Primary hyperparathyroidism
- Physiologic hyperparathyroidism due to low calcium or Vit D intake
- Idiopathic hypercalciuria
- Sarcoidosis
- Children during normal growth
- Pregnancy with lactation
- Vitamin D toxicity
- Tuberculosis
- Lymphoma, some
Decreased in:
- Chronic renal failure with azotemia
- Anephric patients
- Hypoparathyroidism
- Pseudohypoparathyroidism
- 1-α-hydroxylase deficiency, congenital
- Postmenopausal osteoporosis
- Osteomalacia, tumor-induced
- Vitamin D-dependant rickets
- Vitamin D-resistant rickets (familial hypophosphatemia)
Males
<16 years: 23-85 pg/mL
>16 years: 18-64 pg/mL
Females
<16 years: 23-85 pg/mL
>16 years: 18-78 pg/mL
Serum (SST) or Plasma Heparin (Green) top tube.
Stability
- Ambient: 72 hours
- Refrigerated: 7-14 days
- Frozen: 28 days
- Clin Lab Med. 2000;20:569. [PMID: 10986622]
- Eur J Endocrinol. 2006;155:237. [PMID: 16868136]
- Drug Ther Bull. 2006;44:25. [PMID: 16617932]
- Expert Opin Pharmacother. 2008 Jan;9(1):107-18. [PMID: 18076342]
- Altern Med Rev. 2008 Mar;13(1):6-20. [PMID: 18377099]
- Bishop ML, Duben-Engelkirk JL, and Fody EP. Clinical Chemistry Principles, Procedures, Correlations. Philadelphia. Lippincott (1996).
- Food Nutr Res. 2013 May 16;57. [PMID: 23687486]